Literature DB >> 7814529

Comparison of methods for detection of hepatitis B virus DNA.

H L Zaaijer1, F ter Borg, H T Cuypers, M C Hermus, P N Lelie.   

Abstract

We compared the performance of four assays for detection of hepatitis B virus (HBV) DNA: the PCR; the branched DNA hybridization assay (Chiron); and two hybridization assays that use liquid hybridization (Abbott) or direct membrane hybridization (MH). Testing 109 random hepatitis B surface antigen-positive patient samples, the percentages found to be HBV DNA positive among 30 hepatitis B e antigen (HBeAg)-positive samples and 79 HBeAg-negative samples were as follows: PCR, 100 and 90%; Chiron, 73 and 25%; Abbott, 67 and 13%; and MH, 40 and 8%. In six hepatitis B surface antigen-positive, HBeAg-negative samples, all three hybridization assays detected HBV DNA. Testing dilutions prepared from the Eurohep HBV DNA standards, the detection limits of the assays appeared to be the following: PCR, 2.5 x 10(2) HBV genomes per ml; Chiron, 2.5 x 10(6) genomes per ml; and Abbott and MH, 2.5 x 10(7) genomes per ml. HBV DNA levels in the dilution series, as reported by the Chiron and MH assays, were, on average, 2 times higher than calculated; the Abbott results were, on average, 19 times lower than calculated. We concluded that high levels of HBV DNA and the presence of HBeAg do not necessarily coincide, that the application of hybridization assays is limited to the monitoring of relatively high levels of HBV DNA, and that further standardization of quantitative HBV DNA assays is necessary to facilitate comparison of HBV DNA levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814529      PMCID: PMC263947          DOI: 10.1128/jcm.32.9.2088-2091.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

Review 1.  Genetic variation in hepatitis B virus.

Authors:  W F Carman; H C Thomas
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

2.  Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses.

Authors:  M S Urdea; T Horn; T J Fultz; M Anderson; J A Running; S Hamren; D Ahle; C A Chang
Journal:  Nucleic Acids Symp Ser       Date:  1991

Review 3.  Chronic type B hepatitis and the "healthy" HBsAg carrier state.

Authors:  J H Hoofnagle; D A Shafritz; H Popper
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

4.  Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.

Authors:  A Fujiyama; A Miyanohara; C Nozaki; T Yoneyama; N Ohtomo; K Matsubara
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

5.  Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay.

Authors:  S Kaneko; R H Miller; S M Feinstone; M Unoura; K Kobayashi; N Hattori; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  Rapid identification of low level hepatitis B-related viral genome in serum.

Authors:  T J Liang; K J Isselbacher; J R Wands
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

  6 in total
  32 in total

1.  A multicenter study evaluation of the digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards.

Authors:  H G Niesters; M Krajden; L Cork; M de Medina; M Hill; E Fries; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Identification of different states of hepatitis B virus infection with a quantitative PCR assay.

Authors:  H H Kessler; S Preininger; E Stelzl; E Daghofer; B I Santner; E Marth; H Lackner; R E Stauber
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

3.  Relationship between body surface area and ALT normalization after long-term lamivudine treatment.

Authors:  Makoto Nakamuta; Shusuke Morizono; Yuichi Tanabe; Eiji Kajiwara; Junya Shimono; Akihide Masumoto; Toshihiro Maruyama; Norihiro Furusyo; Hideyuki Nomura; Hironori Sakai; Kazuhiro Takahashi; Koichi Azuma; Shinji Shimoda; Kazuhiro Kotoh; Munechika Enjoji; Jun Hayashi
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

4.  Detection of cytomegalovirus in blood donors by PCR using the digene SHARP signal system assay: effects of sample preparation and detection methodology.

Authors:  M Krajden; P Shankaran; C Bourke; W Lau
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

5.  A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml.

Authors:  M L Collins; B Irvine; D Tyner; E Fine; C Zayati; C Chang; T Horn; D Ahle; J Detmer; L P Shen; J Kolberg; S Bushnell; M S Urdea; D D Ho
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

6.  Comparative evaluation of semiautomated COBAS AMPLICOR hepatitis B virus (HBV) monitor test and manual microwell plate-based AMPLICOR HBV MONITOR test.

Authors:  I J Marin; M Poljak; K Seme; J Meglic-Volkar; M Maticic; G Lesnicar; V Brinovec
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

7.  New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA.

Authors:  Tatsuji Kimura; Akinori Rokuhara; Akihiro Matsumoto; Shintaro Yagi; Eiji Tanaka; Kendo Kiyosawa; Noboru Maki
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence.

Authors:  A Erhardt; S Schaefer; N Athanassiou; M Kann; W H Gerlich
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

9.  Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.

Authors:  F ter Borg; S Smorenburg; R A de Man; R C Rietbroek; R A Chamuleau; E A Jones
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

10.  Nuclease-resistant double-stranded DNA controls or standards for hepatitis B virus nucleic acid amplification assays.

Authors:  Shuang Meng; Sien Zhan; Jinming Li
Journal:  Virol J       Date:  2009-12-22       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.